Secretions of bifidobacterium infantis and lactobacillus acidophilus protect intestinal epithelial barrier function

Journal of Pediatric Gastroenterology and Nutrition

Volumn 64, Issue 3, 2017, Pages 404-412

  Guo, Shuangshuang ^a,b   Gillingham, Tyler ^a   Guo, Yuming ^b   Meng, Di ^a   Zhu, Weishu ^a   Allen Walker, W ^a   Ganguli, Kriston ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Caco 2 cell monolayer; IL 1b; NF B p65; tight junction

Indexed keywords

CLAUDIN 1; INTERLEUKIN 1BETA; OCCLUDIN; PROBIOTIC AGENT; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR RELA; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ARTICLE; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CACO-2 CELL LINE; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTESTINAL EPITHELIAL BARRIER FUNCTION; INTESTINE CELL; INTESTINE FUNCTION; LACTOBACILLUS ACIDOPHILUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; WESTERN BLOTTING; FLUORESCENT ANTIBODY TECHNIQUE; INTESTINE MUCOSA; METABOLISM; PERMEABILITY; TIGHT JUNCTION;

BIFIDOBACTERIUM LONGUM SUBSPECIES INFANTIS; BIOMARKERS; BLOTTING, WESTERN; CACO-2 CELLS; CLAUDIN-1; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; LACTOBACILLUS ACIDOPHILUS; NF-KAPPA B; OCCLUDIN; PERMEABILITY; PROBIOTICS; TIGHT JUNCTIONS;

EID: 84975484945     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000001310     Document Type: Article

References (47)

1. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: A review of clinical trials. Proc Nutr Soc 2007;66:307-15.
2. Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008;32:127-37.
3. Cabana MD. Early probiotic supplementation for the prevention of atopic disease in newborns-probiotics and the hygiene hypothesis. Biosci Microflora 2011;30:129-33.
4. OHara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006;7:688-93.
5. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, et al. Probiotic mechanisms of action. Ann Nutr Metab 2012;61:160-74.
6. Mennigen R, Nolte K, Rijcken E, et al. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 2009;296:G1140-9.
7. Wang H, Gong J, Wang W, et al. Are there any different effects of Bifidobacterium, Lactobacillus and Streptococcus on intestinal sensation, barrier function and intestinal immunity in PI-IBS mouse model? PLoS One 2014;9:e90153.
8. Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005;115:178-81.
9. Borriello SP, Hammes WP, Holzapfel W, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003;36:775-80.
10. Antony SJ. Lactobacillemia: An emerging cause of infection in both the immunocompromised and the immunocompetent host. J Natl Med Assoc 2000;92:83-6.
11. Tao Y, Drabik KA, Waypa TS, et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells.AmJ Physiol Cell Physiol 2006;290:C1018-30.
12. Ewaschuk JB, Diaz H, Meddings L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008;295:G1025-34.
13. Petrof EO, Claud EC, Sun J, et al. Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 2009;15:1537-47.
14. Yan F, Polk DB. Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes 2012;3:25-8.
15. Liu Z, Shen T, Zhang P, et al. Lactobacillus plantarum surface layer adhesive protein protects intestinal epithelial cells against tight junction injury induced by enteropathogenic Escherichia coli. Mol Biol Rep 2011;38:3471-80.
16. Segawa S, Fujiya M, Konishi H, et al. Probiotic-derived polyphosphate enhances the epithelial barrier function and maintains intestinal homeostasis through integrin-p38 MAPK pathway. PLoS One 2011;6:e23278.
17. Zakostelska Z, Kverka M, Klimesova K, et al. Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One 2011;6:e27961.
18. Ganguli K, Meng D, Rautava S, et al. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 2012;304:G132-41.
19. Guo S, Guo Y, Ergun A, et al. Secreted metabolites of Bifidobacterium infantis and Lactobacillus acidophilus protect immature human enterocytes from IL-1b-induced inflammation: A transcription profiling analysis. PLoS One 2015;10:e0124549.
20. Al-Sadi RM, Ma TY. IL-1b causes an increase in intestinal epithelial tight junction permeability. J Immunol 2007;178:4641-9.
21. Sanderson IR, Ezzell RM, Kedinger M, et al. Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc Natl Acad Sci U S A 1996;93:7717-22.
22. Ma TY, Hoa NT, Tran DD, et al. Cytochalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am J Gastrointest Liver Physiol 2000;279:G875-85.
23. Oppong GO, Rapsinski GJ, Newman TN, et al. Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut. Infect Immun 2013;81:478-86.
24. Fanning AS, Mitic LL, Anderson JM. Transmembrane proteins in the tight junction barrier. J Am Soc Nephrol 1999;10:1337-45.
25. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 2002;34:385-96.
26. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 2000;279:G851-7.
27. Bruewer M, Samarin S, Nusrat A. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci 2006;1072:242-52.
28. Shen L, Turner JR. Role of epithelial cells in initiation and propagation of intestinal inflammation. Eliminating the static: Tight junction dynamics exposed. Am J Physiol Gastrointest Liver Physiol 2006;290:G577-82.
29. Ligumsky M, Simon PL, Karmeli F, et al. Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-9.
30. Bhatia AM, Stoll BJ, Cismowski MJ, et al. Cytokine levels in the preterm infant with neonatal intestinal injury. Am J Perinatol 2014;31:489-96.
31. Al-Sadi R, Guo S, Dokladny K, et al. Mechanism of interleukin-1b induced-increase in mouse intestinal permeability in vivo. J Interferon Cytokine Res 2012;32:474-84.
32. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001;121:580-91.
33. Corridoni D, Pastorelli L, Mattioli B, et al. Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNFdependent mechanism. PLoS One 2012;7:e42067.
34. Poritz LS, Harris LR 3rd, Kelly AA, et al. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011;56: 2802-9.
35. Balda MS, Whitney JA, Flores C, et al. Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 1996;134:1031-49.
36. Shi CZ, Chen HQ, Liang Y, et al. Combined probiotic bacteria promotes intestinal epithelial barrier function in interleukin-10-gene-deficient mice. World J Gastroenterol 2014;20:4636-47.
37. Nébot-Vivinus M, Harkat C, Bzioueche H, et al. Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol 2014;20:6832-43.
38. Karczewski J, Troost FJ, Konings I, et al. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010;298:G851-9.
39. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64.
40. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
41. Lin H-C, Su B-H, Chen A-C, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005;115:1-4.
42. Bergmann KR, Liu SXL, Tian R, et al. Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing enterocolitis. Am J Pathol 2013;182:1595-606.
43. Al-Sadi R, Guo S, Ye D, et al. Mechanism of IL-1b modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J Immunol 2013;190: 6596-606.
44. Al-Sadi R, Ye D, Dokladny K, et al. Mechanism of IL-1b-induced increase in intestinal epithelial tight junction permeability. J Immunol 2008;180:5653-61.
45. Al-Sadi R, Ye D, Said HM, et al. Cellular and molecular mechanism of interleukin-1b modulation of Caco-2 intestinal epithelial tight junction barrier. J Cell Mol Med 2011;15:970-82.
46. Ghosh G, Wang VY, Huang DB, et al. NF-kB regulation: lessons from structures. Immunol Rev 2012;246:36-58.
47. Ghadimi D, De Vrese M, Heller KJ, et al. Effect of natural commensalorigin DNA on Toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integrity of polarized intestinal epithelial cells. Inflamm Bowel Dis 2010;16:410-27.